Area of research
Neurology · Physiology
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Alzheimer's disease research and treatments, Cholesterol and Lipid Metabolism, and Amyotrophic Lateral Sclerosis Research.
Distinct <scp>AQP4</scp> Alterations in Movement Disorders with Primary Synucleinopathy
Human Endogenous Retroviruses in Neurodegenerative Diseases
A protective role of ABCA5 in response to elevated sphingomyelin levels in Parkinson’s disease
Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting
Role of Oligodendrocyte Lineage Cells in Multiple System Atrophy
Lipid pathway dysfunction is prevalent in patients with Parkinson’s disease
Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain
Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis
Multiple pathways of lipid dysregulation in amyotrophic lateral sclerosis
LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
Comparison of Different Platform Immunoassays for the Measurement of Plasma Alpha-Synuclein in Parkinson’s Disease Patients
Pathological manifestation of human endogenous retrovirus K in frontotemporal dementia
Increased VLCFA-lipids and ELOVL4 underlie neurodegeneration in frontotemporal dementia
Altered serum protein levels in frontotemporal dementia and amyotrophic lateral sclerosis indicate calcium and immunity dysregulation
Uncovering pathophysiological changes in frontotemporal dementia using serum lipids
Structural heterogeneity of α-synuclein fibrils amplified from patient brain extracts
Arylsulfatase A, a genetic modifier of Parkinson’s disease, is an α-synuclein chaperone
Eating peptides: biomarkers of neurodegeneration in amyotrophic lateral sclerosis and frontotemporal dementia
Reduced glucocerebrosidase activity in monocytes from patients with Parkinson’s disease
Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development
Effect of Fluvoxamine on Amyloid-β Peptide Generation and Memory
Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies
Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition
Reduced glucocerebrosidase is associated with increased α-synuclein in sporadic Parkinson’s disease
Deletion of<i>Abca7</i>Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease
DNA methylation of the <i>MAPT</i> gene in Parkinson's disease cohorts and modulation by vitamin E <i>In Vitro</i>
Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases